UAN #: 0387-0000-19-178-H04-P
CE Expiration: 01/14/2022, 11:59 PM ( ET )
Available CE: CME, CNE, CEU, CPH, CHES, CPE, AAVSB
COCA Calls/Webinars are designed to increase clinicians` knowledge and competencies of threats to the public`s health, their effects on human populations and evaluation, and management strategies of these threats.
Topics Covered: Public Health Emergencies
In the United States, about 2,000 cases of malaria are imported each year, 300 of which are severe. There is no FDA-approved drug available to treat severe malaria. Intravenous (IV) artesunate, which is neither FDA-approved nor commercially available, is currently the first-line drug to treat severe malaria in the United States. Since April 1, 2019, all U.S. clinicians must call the Centers for Disease Control and Prevention (CDC) to obtain IV artesunate to treat cases of severe malaria.
During this COCA Call, clinicians will learn about CDC’s updated guidance for using IV artesunate—a life-saving drug—to treat patients with severe malaria in the United States, and will receive an update on CDC’s artesunate program.